Dava Home

Sale!
, ,

Dapadax-GM 10/1/1000 – Dapagliflozin, Glimepiride & Metformin Hydrochloride (Extended Release) Tablets

Original price was: ₹125.44.Current price is: ₹60.21.

Dapadax-GM 10/1/1000 is a triple-combination extended-release tablet designed to support comprehensive blood sugar management in adults with type 2 diabetes.

Add to Wishlist
Add to Wishlist

Dapadax-GM 10/1/1000 Tablets combine Dapagliflozin, Glimepiride, and Metformin Hydrochloride in an extended-release formulation to provide multi-pathway glycemic support.

Dapagliflozin promotes removal of excess glucose through urine, Glimepiride supports insulin release from the pancreas, and Metformin helps reduce hepatic glucose production while improving insulin sensitivity.

The extended-release formulation allows gradual medicine release to help maintain stable blood glucose levels when used as directed.

 Key Benefits

Triple-action blood glucose support
Extended-release formulation
Helps improve insulin sensitivity
Supports pancreatic insulin response
Convenient tablet dosage form

 Directions for Use

Take as directed
Swallow whole, do not crush or chew
Preferably take with meals
Maintain recommended diet and exercise routine

 Safety & Precautions

Do not exceed recommended dosage
Monitor blood glucose regularly
Use caution in kidney, liver, or heart conditions
May cause mild gastrointestinal discomfort
Discontinue use and consult a healthcare professional if adverse reactions occur

 Storage

Store in a cool, dry place
Protect from moisture and heat
Keep out of reach of children

Weight 0.01 g
Dimensions 12 × 8 × 4 cm
Composition

Dapagliflozin + Glimepiride + Metformin Hydrochloride (ER)

Strength

10 mg / 1 mg / 1000 mg

Dosage Form

Extended-Release Tablet

Uses

Supports blood glucose management
Helps improve glycemic control
Adjunct to diet and exercise

Reviews

There are no reviews yet.

Be the first to review “Dapadax-GM 10/1/1000 – Dapagliflozin, Glimepiride & Metformin Hydrochloride (Extended Release) Tablets”
Scroll to Top